Dr Reddy’s shares in focus after This fall web revenue tumbles 86% YoY; Morgan Stanley, Goldman Sachs weigh in
Shares of Dr Reddy's Laboratories will stay in give attention to Wednesday after the pharma large reported 86% year-on-year (YoY)...
Reddys
